Charanjit Rihal, MD
Cardiovascular Disease · Rochester, MNNPI 1508845991
Payments from drug & device makers
What this record shows
This record is dominated by other: $473,082 of the $477,938 with a category attached, or 99.0%. Edwards Lifesciences accounts for 99.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $473,082 and has fallen 99.8% since, to $787 in 2025. Among cardiovascular disease clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 35 payments — averaging $13,655 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$477K
- Abbott$403
- Livanova USA, Inc.$216
- Medtronic$59
Across 103 payments — averaging $8734.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$768K
- Livanova USA, Inc.$72K
- Abbott$56K
- Boston Scientific$3K
What the payments were for
- Speaking & faculty fees$1,4000%
- Travel & lodging$9020%
- Food & beverage$2,5541%
- Other$473,08299%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 27 | $477,260 |
| Abbott | 4 | $403 |
| Livanova USA, Inc. | 2 | $216 |
| Medtronic | 2 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$477,938 in reported general payments places this provider in the 95th percentile of 451 cardiovascular disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Rochester
- Srijoy MahapatraRochester$1.2M
- Amir LermanRochester$465K
- Martha GroganRochester$330K
- Virend SomersRochester$262K
- Francisco Lopez-JimenezRochester$167K
- Ammar KilluRochester$139K
- Allan JaffeRochester$111K
- Robert McBaneRochester$110K
- Michael McGoonRochester$106K
- R Scott WrightRochester$95K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.